Calendar Companies Compare Analytics Learn Watchlist

Search CatalystAlert

Search for companies, drugs, and catalysts

Loading market movers...

Free biotech catalyst calendar tracking FDA decisions, clinical trial results, and PDUFA dates for biotech stocks.

Quick Links

Catalyst Calendar
Search Companies
Biotech Glossary
Therapeutic Areas

Legal

About
Privacy
Terms

Data Sources

ClinicalTrials.gov
SEC EDGAR
FDA

© 2025 CatalystAlert. All rights reserved.

Not financial advice. Data may be delayed or incomplete.

All Therapeutic Areas

🛡️

Immunology & Inflammation

100 drugs in pipeline from 10 companies

100

Drugs in Pipeline

10

Companies

3

Upcoming Catalysts

51

Phase 3 Trials

Upcoming Catalysts

Dec 2025~

LLY⭐Phase 3Phase 3

Ixekizumab Phase 3 Results Expected

Ixekizumab • Psoriasis

Jan 2026~

ANABPhase 2Phase 2

Placebo Phase 2 Results Expected

Placebo • Atopic Dermatitis

Jan 2026~

ANABPhase 2Phase 2

Rosnilimab Phase 2 Results Expected

Rosnilimab • Rheumatoid Arthritis

View all catalysts

Pipeline by Phase

Phase 3

51

Phase 2

49

Active Companies

Amphastar Pharmaceuticals, Inc.

Astellas Pharma Inc.

Arcutis Biotherapeutics, Inc.

Sanofi

TENAX THERAPEUTICS, INC.

Eisai Co., Ltd.

Kyowa Kirin Co., Ltd.

Eli Lilly and Company

Incyte Corporation

Coherus Oncology, Inc.

Related Conditions

autoimmunerheumatoid arthritislupuspsoriasiscrohnulcerative colitisibdinflammatoryimmuneimmunologyeczemadermatitisankylosing spondylitismultiple sclerosisgrafttransplantrejectionallergyasthma